Tech Company Financing Transactions

EnPlusOne Biosciences Funding Round

Breakout Ventures, Northpond Ventures and private investors participated in a $10 million funding round for EnPlusOne Biosciences. The financing was announced on 2/19/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

313 Pleasant St. 4W
Watertown, MA 02472
USA

Phone

Undisclosed

Website

www.enplusonebio.com

Email Address

[email protected]

Overview

Chemical synthesis cannot keep pace with RNA innovation. Our proprietary ezRNA� platform builds RNA enzymatically and promises long-term manufacturing solutions to sustainably deliver RNA therapeutics at scale.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Wiegand

        

Chief Operating Officer

Dan Ahlstedt

        

Chief Scientific Officer

Jonathan Rittichier

        

Co-Founder

George Church

        

Co-Founder

Howon Lee

        

Browse more venture capital transactions:

Prev: 2/19/2025: Blockaid venture capital transaction
Next: 2/19/2025: VitalConnect venture capital transaction

Share this article

Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary